Patient Adherence Program Design

Not Found

Sorry, but no results were found. Please use our navigation or search to find what you are looking for.

Are there more challenges with the new lower priced Repatha NDC compared with the higher priced NDC?

Yes: 57.1%

No: 42.9%

Do you think brand manufacturer’s strategy to introduce a lower priced brand NDC of an existing product is going to expand in 2019?

Yes: 85.7%

No: 14.3%

Will there be a(n) ______ number of pharmaceutical product price changes in 2019 compared to 2018?

Increased: 63.64%

Decreased: 0.00%

Similar: 36.36%

Do you believe there are sufficient treatment options for HIV to warrant formulary exclusions?

Yes: 75%

No: 25%

Do you believe there are sufficient treatment options for Hemophilia to warrant formulary exclusions?

Yes: 71%

No: 29%

Do you believe there are sufficient treatment options for Hereditary Angioedema to warrant formulary exclusions?

Yes: 17%

No: 83%